JAK Inhibitors: Uses, Side Effects, and How They Work

Introduction: Key Points About JAK Inhibitors

JAK inhibitors, also known as Janus kinase inhibitors, are a class of medications used to treat autoimmune and inflammatory conditions, such as rheumatoid arthritis and certain skin disorders. These drugs work by blocking specific enzymes that contribute to inflammation in the body. JAK inhibitors are typically prescribed when other treatments have not been effective. Taken orally, they can help alleviate symptoms like pain, swelling, and stiffness.

Medications in the JAK Inhibitor Drug Class

Common JAK inhibitor medications include:

1. Abrocitinib (Abrocitinib)
2. Baricitinib (Baricitinib)
3. Filgotinib (Filgotinib)
4. Tofacitinib (Tofacitinib)

The “generic name” refers to the official medical name of the drug, while the brand name is the one given by the manufacturer. The generic name is listed in parentheses.

How JAK Inhibitors Work: Mechanism of Action

JAK inhibitors block the activity of Janus kinase (JAK) enzymes, which play a crucial role in signaling pathways that trigger inflammation and immune system activation. By inhibiting these enzymes, JAK inhibitors reduce the production of inflammatory proteins, helping to decrease inflammation. While all JAK inhibitors target these enzymes, some may be more selective for specific JAK enzymes, which can influence their effectiveness and potential side effects.

Benefits of JAK Inhibitor Therapy

JAK inhibitors are often prescribed for autoimmune diseases like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, particularly when other treatments, such as biologics or methotrexate, have not provided sufficient relief. These medications are sometimes preferred because they are taken orally, unlike many biologics that require injections. Additionally, JAK inhibitors may offer faster symptom relief compared to other treatments. They are also a valuable option for patients who do not respond well to traditional therapies.

Potential Side Effects of JAK Inhibitors

Like all medications, JAK inhibitors can cause side effects. It’s important to be aware of these potential reactions and discuss any concerns with your healthcare provider before starting treatment. While some side effects are common and mild, others can be more serious. Below is a list of potential side effects, starting with the most common.

Common Side Effects of JAK Inhibitors (Greater than 1% Occurrence)

1. Upper respiratory tract infections (16-20%): Symptoms may include a runny nose, sore throat, and cough. Patients with a history of frequent infections may be at higher risk.
2. Headache (7-10%): Mild to moderate headaches are commonly reported and are usually manageable with over-the-counter pain relief.
3. Increased cholesterol levels (5-10%): JAK inhibitors can raise cholesterol levels, so regular monitoring is important, especially for patients with pre-existing heart disease or high cholesterol.
4. Nausea (3-5%): Some patients may experience mild nausea, which can often be managed by taking the medication with food.
5. Diarrhea (2-4%): Diarrhea is a common side effect but is usually mild and temporary. Staying hydrated is important if this occurs.
6. Anemia (2-4%): JAK inhibitors can lower red blood cell counts, leading to anemia. This is more common in patients already at risk for low blood counts.
7. Increased liver enzymes (1-3%): Elevated liver enzymes may indicate liver irritation or damage. Regular blood tests are recommended to monitor liver function.

Less Common Side Effects of JAK Inhibitors (Less than 1% Occurrence)

These side effects are rare but can still occur. If you experience any of the following, contact your healthcare provider:

1. Blood clots
2. Serious infections (e.g., tuberculosis, shingles)
3. Gastrointestinal perforation
4. Heart attack or stroke
5. Skin rash
6. Fatigue
7. Weight gain

Severe Side Effects of JAK Inhibitors

Some side effects of JAK inhibitors can be severe and require immediate medical attention. These include:

1. Blood clots: JAK inhibitors have been associated with an increased risk of blood clots in the veins and lungs. Symptoms may include swelling, pain, and redness in the legs, or sudden shortness of breath.
2. Serious infections: Because JAK inhibitors suppress the immune system, they can increase the risk of serious infections, including tuberculosis and shingles. Patients with a history of chronic infections or those who are immunocompromised are at higher risk.
3. Heart attack or stroke: There is a small but significant risk of cardiovascular events, especially in patients with pre-existing heart conditions.
4. Cancer: Long-term use of JAK inhibitors may increase the risk of certain cancers, such as lymphoma and skin cancer.

If you experience any of these severe side effects, stop taking the medication and contact your healthcare provider immediately. It’s crucial to have a thorough discussion with your doctor before starting JAK inhibitors to weigh the risks and benefits, especially if you have a history of heart disease, blood clots, or infections.

Drug to Drug Interactions with JAK Inhibitors

JAK inhibitors, also known as Janus kinase inhibitors, can interact with other medications, potentially increasing side effects or reducing the effectiveness of your treatment. Below are some common drug interactions to be mindful of during JAK inhibitor therapy:

1. Biologic therapies (e.g., TNF inhibitors): Combining JAK inhibitors with biologic therapies can significantly raise the risk of serious infections.
2. Immunosuppressants (e.g., cyclosporine, azathioprine): Using JAK inhibitors alongside other immunosuppressants can further weaken the immune system, increasing the likelihood of infections.
3. Blood thinners (e.g., warfarin, aspirin): JAK inhibitors may heighten the risk of bleeding when taken with blood thinners.
4. Live vaccines: Patients on JAK inhibitors should avoid live vaccines, as the medication can reduce the body’s ability to mount an immune response, increasing the risk of infection.
5. Strong CYP3A4 inhibitors (e.g., ketoconazole): These drugs can raise JAK inhibitor levels in the bloodstream, potentially leading to more pronounced side effects.

Always inform your healthcare provider about all medications and supplements you are taking before starting JAK inhibitors. This will help your provider assess potential interactions and adjust your treatment plan as needed.

Precautions and Contraindications for JAK Inhibitors

Before starting JAK inhibitors, it’s important to consider certain precautions and contraindications. These factors may increase the risk of side effects or make the medication unsuitable for some individuals.

1. Pre-existing infections: Patients with active or chronic infections should not begin JAK inhibitors until the infection is fully treated, as the medication can suppress the immune system, making it harder to fight infections.
2. History of blood clots: If you have a history of blood clots, your doctor may recommend alternative treatments, as JAK inhibitors can increase the risk of clot formation.
3. Heart disease: Patients with a history of heart disease or stroke should be closely monitored while taking JAK inhibitors due to the increased risk of cardiovascular events.
4. Liver disease: JAK inhibitors can affect liver function, so patients with liver disease should undergo regular blood tests to monitor liver health.
5. Pregnancy and breastfeeding: JAK inhibitors are not recommended during pregnancy or breastfeeding, as they may pose risks to the baby. Women of childbearing age should use effective contraception while on this medication.

It’s essential to discuss your complete medical history with your healthcare provider before starting JAK inhibitors to ensure the medication is safe and appropriate for you.

Conclusion: Understanding JAK Inhibitors and Your Treatment

JAK inhibitors, or Janus kinase inhibitors, are an effective treatment option for several autoimmune conditions. However, like all medications, they come with potential risks and side effects. It’s important to have an open conversation with your healthcare provider to understand how these medications may affect you, especially if you have other health conditions or are taking additional medications.

If you’re considering starting JAK inhibitors or have questions about your current treatment, our telemedicine providers are available to help. Schedule an appointment today to discuss your options and receive personalized care from the comfort of your home.

James Kingsley

Learn More